Navigation Links
Tamiflu-resistant influenza: Parsing the genome for the culprits
Date:3/31/2014

Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus' genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus' formidable adaptability. They were able to find mutations that conferred resistance that had up to this point not yet been identified. Their software has been made freely available to researchers everywhere, and is the subject of an article published in the journal PLOS Genetics.

Widespread use of Tamiflu leads to resistance

In theory, Tamiflu should only be used by patients in fragile health. But during the 2008-2009 flu season, the drug was used for the first time on a very wide scale. Resistant strains of the virus appeared within just a few weeks. Fortunately, even though the mutation induced a resistance to Tamiflu, it also caused a reduction in the replication rate of the virus. Once the use of the antiviral was dialed back to a more reasonable level, the resistant strains lost their competitive advantage, and they disappeared, submerged by competitors that were sensitive to the drug but had a higher rate of replication.

Resistance always results from random mutations, says Jeffrey Jensen, co-author of the EPFL study. But when a mutation leads to a competitive advantage, for example the ability to resist against a source of aggression, it tends to be passed on to its descendants. "A priori, nothing distinguishes one mutation from another; they're all the result of chance. Our goal is precisely to be able to tell the difference between mutations that make the virus resistant to Tamiflu, thus leading to a selection ph
'/>"/>

Contact: Lionel Pousaz
lionel.pousaz@epfl.ch
41-795-597-161
Ecole Polytechnique Fdrale de Lausanne
Source:Eurekalert

Page: 1 2

Related biology news :

1. Better preparedness against Tamiflu-resistant influenza viruses
2. H7N9 influenza: History of similar viruses gives cause for concern
3. Research from CHORI scientists demonstrates first genome methylation in fruit fly
4. Genome-wide association studies mislead on cardiac arrhythmia risk gene
5. In the genome of loblolly pine lies hope for better resistance to a damaging disease
6. Loblolly pine genome is largest ever sequenced
7. Loblolly pines immense genome conquered
8. Newly identified small-RNA pathway defends genome against the enemy within
9. The genome of sesame sheds new lights on oil biosynthesis
10. Scripps Wellderly Genome Resource now available to researchers
11. Pond-dwelling powerhouses genome points to its biofuel potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... at San Antonio and The University of Texas at ... than $750,000 in grants through the San Antonio Life ... SALSI is a model of how a general academic ... forces for greater research and graduate education. , The ... public health issues and diseases of global impact. Funding ...
(Date:8/19/2014)... August 2014: An engineer at the University of Liverpool ... a brain to communicate with the body. , Dr ... Mahadevan, has developed a mathematical model for earthworms and ... these soft bodied animals get around. , The most ... generator (CPG) which states that the central brain of ...
(Date:8/19/2014)... study that analyzed concentrations of African dust transported ... winter and spring. These research findings offer new ... quality impacts of African dust, including the climate ... occur from increased African dust emissions in the ... (UM) Rosenstiel School of Marine and Atmospheric Science ...
Breaking Biology News(10 mins):San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3Secrets of how worms wriggle uncovered 2Study of African dust transport to South America reveals air quality impacts 2
... , The University of Haifa, Israel, has dedicated Israel,s ... focus on research and development of non-irrigated green roofs; ... and evolutionary theories. The center has been ... expert in the field, and was facilitated by VP ...
... Investigators at Washington University and The Scripps Research Institute ... to facilitate meta-analyses on studies of the metabolism of ... of the Global Metabolomic Initiative was sent to more ... a total of more than 35,000 files of metabolomic ...
... und MÜNCHEN, 7. November 2012 Bausch + Lomb, ... er seine Option zum Kauf aller im Umlauf befindlichen ... GmbH (TPV) ausgeübt hat, einem führenden Hersteller ophthalmologischer Lasersysteme. ... aus einem Joint Venture zwischen Bausch + Lomb und ...
Cached Biology News:Israel's first Green Roofs Ecology research center dedicated at University of Haifa 2Global metabolomic initiative announced 2Global metabolomic initiative announced 3Global metabolomic initiative announced 4Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 2Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 3Bausch + Lomb übernimmt Technolas Perfect Vision GmbH 4
(Date:8/19/2014)... CA (PRWEB) August 19, 2014 Robin ... Parkinson’s disease can take on an individual. Symptoms ... decreased facial expression, problems swallowing and severe depression. ... the dying off of dopamine producing neurons of the ... from a disease that slowly and progressively gets worse, ...
(Date:8/19/2014)... , Aug. 19, 2014 ... addition of the "Spectroscopy Equipment and ... report to their offering. ... Spectroscopy Equipment and Accessories in US$ Thousands ... (UV-Vis spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near ...
(Date:8/19/2014)... In November 2012, the European Union (EU) mandated use ... a new PSUR – responding to the increasing need to ... drug. Adopted in many regions, the main objectives of the ... and critical analysis of new or emerging information on the ... evidence of the potential benefits of a drug; and , ...
(Date:8/19/2014)... Aug. 19, 2014 /PRNewswire/ - iCo Therapeutics Inc. ("iCo" ... reported results of its Oral Amphotericin B (Oral ... The study, conducted by ImmuneCarta®, the immune monitoring ... effectiveness of Oral Amp B in reactivating ... individuals despite intensive treatment with antiretroviral therapy. ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3
... Inc. (NASDAQ: AUXL ), a specialty biopharmaceutical ... of post-approval use in the U.S. of XIAFLEX® for ... palpable cord.  After approximately 11,000 injections administered to approximately ... meaningful change in the nature of events expected relative ...
... 2011 Genprex, Inc., formerly known as Convergen ... nanomolecular cancer therapy CNVN202, will be branded as Oncoprex™ ... brand in the oncology sector in recognition of our ... will be used to unlock the unrealized potential of ...
... - QIAGEN assay for JAK2 V617F mutation ... ,JAK2 inhibitor, and to monitor responses to therapy ... exclusive access to JAK2 biomarker underpins potential future expansion with ... QGEN ; Frankfurt, Prime Standard: QIA) today announced that ...
Cached Biology Technology:Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 2Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 3Auxilium Pharmaceuticals, Inc. Announces 17 Month XIAFLEX® Safety Update 4Genprex Announces New Branding 2QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 2QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 3QIAGEN to Develop New Companion Diagnostic for Compound in Clinical Trials for Blood Cancers 4
... a serine/threonine phosphatase isolated from human red ... heterodimer of 60kDa (A) and 36kDa (C) ... the a-subunit of phosphorylase kinase. With its ... specificity and may play a regulatory role ...
... Monitoring Kit measures adenosine triphosphate ... and a dynamic range. Based ... assay measures ATP in bacterial, ... a concentration range of 10-11 ...
... Jouan RCT series of refrigerated cold traps ... trapping of low volatility/aqueous solvents or high ... and other vacuum concentrators/centrifugal evaporators. Also used ... systems such as used in electron microscopes. ...
96 Well Plate Sterile, RE bottom; consistent medium binding affinity for hydrophobic complexes and proteins....
Biology Products: